Načítá se...
Toxicity‐dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials
Phase I trials of anti‐cancer therapies aim to identify a maximum tolerated dose (MTD), defined as the dose that causes unacceptable toxicity in a target proportion of patients. Both rule‐based and model‐based methods have been proposed for MTD recommendation. The escalation with overdose control (E...
Uloženo v:
| Vydáno v: | Stat Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5462100/ https://ncbi.nlm.nih.gov/pubmed/28295513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.7280 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|